Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1996 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1987 |
100 Clinical Results associated with Xi'an Fanggong Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Xi'an Fanggong Pharmaceutical Co., Ltd.
100 Deals associated with Xi'an Fanggong Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Xi'an Fanggong Pharmaceutical Co., Ltd.